Artwork

المحتوى المقدم من Ari Massoudi. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Ari Massoudi أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !

Dr Jane, PhD-PharmD-MD

17:56
 
مشاركة
 

Manage episode 448476071 series 3273121
المحتوى المقدم من Ari Massoudi. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Ari Massoudi أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.

ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery

👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/


Exciting news! 🚀 Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD Weber, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!

🔬 From Academia to AI-Powered Drug Discovery

Dr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.


🧠 Unveiling Cortex Discovery's Innovative Approach

Discover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:

• Their foundation model for drug property predictions

• The vast database of 750 million data points powering their deep learning system

• Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism


💼 Business Insights and Future Outlook

Get an insider's perspective on:

• Cortex Discovery's unique business model and collaboration opportunities

• Challenges faced in the AI-driven drug discovery landscape

• The company's vision for the future of longevity research and pharmaceutical development

This episode is a must-watch for:

• Biotech and pharmaceutical executives

• Investors in the life sciences sector

• Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine

• Anyone interested in the intersection of AI and drug discovery


Don't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!

👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

109 حلقات

Artwork
iconمشاركة
 
Manage episode 448476071 series 3273121
المحتوى المقدم من Ari Massoudi. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Ari Massoudi أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.

ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery

👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/


Exciting news! 🚀 Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD Weber, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!

🔬 From Academia to AI-Powered Drug Discovery

Dr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.


🧠 Unveiling Cortex Discovery's Innovative Approach

Discover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:

• Their foundation model for drug property predictions

• The vast database of 750 million data points powering their deep learning system

• Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism


💼 Business Insights and Future Outlook

Get an insider's perspective on:

• Cortex Discovery's unique business model and collaboration opportunities

• Challenges faced in the AI-driven drug discovery landscape

• The company's vision for the future of longevity research and pharmaceutical development

This episode is a must-watch for:

• Biotech and pharmaceutical executives

• Investors in the life sciences sector

• Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine

• Anyone interested in the intersection of AI and drug discovery


Don't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!

👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

109 حلقات

كل الحلقات

×
 
Loading …

مرحبًا بك في مشغل أف ام!

يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.

 

دليل مرجعي سريع